Andre Goy, MD
Exciting developments in the treatment of patients with lymphoma were highlighted at the 2018 ASCO Annual Meeting, said Andre Goy, MD, holding out the possibility of treating patients without chemotherapy and even treatment-free remission.
, Goy, chairman and director, chief of Lymphoma, and director of Clinical and Translational Cancer Research at John Theurer Cancer Center, discussed some of the most important lymphoma data presented at the 2018 ASCO Annual Meeting and potential future directions for treatment.
OncLive: What were some of the highlights of this year’s ASCO Annual Meeting?
Five years ago, we did not think that immunotherapy would be where it is now. This was one of the first topics that is all over ASCO and is changing the field.
... to read the full story